Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia

Cancer

Volumn 117, Issue 7, 2011, Pages 1470-1477

  Friese, Christopher R ^a   Earle, Craig C ^b   Magazu, Lysa S ^c   Brown, Jennifer R ^d   Neville, Bridget A ^d   Hevelone, Nathanael D ^e   Richardson, Lisa C ^f   Abel, Gregory A ^d  

^a UNIVERSITY OF MICHIGAN SCHOOL OF NURSING   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

chronic lymphocytic leukemia; diagnosis; flow cytometry; outcomes; SEER Medicare

Indexed keywords

AGE; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; COMORBIDITY; CONTROLLED STUDY; DELAYED DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PREDICTION; PRIORITY JOURNAL; RECIPIENT; SEX; SURVIVAL TIME; SYMPTOMATOLOGY; TEACHING HOSPITAL; URBAN AREA;

AGED; AGED, 80 AND OVER; DATABASES AS TOPIC; DELAYED DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MEDICARE; SEER PROGRAM; SOCIOECONOMIC FACTORS; TIME FACTORS; UNITED STATES;

EID: 79952855715     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25655     Document Type: Article

References (32)

1. Arbman G, Nilsson E, Storgren-Fordell V, Sjodahl R., A short diagnostic delay is more important for rectal cancer than for colonic cancer. Eur J Surg. 1996; 162: 899-904.
2. DerKinderen DJ, Koten JW, Van Romunde LK, et al. Early diagnosis of bilateral retinoblastoma reduces death and blindness. Int J Cancer. 1989; 44: 35-39. (Pubitemid 19184673)
3. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD., The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999; 79: 858-864. (Pubitemid 29082117)
4. Rossi S, Cinini C, Di Pietro C, et al. Diagnostic delay in breast cancer: correlation with disease stage and prognosis. Tumori. 1990; 76: 559-562.
5. Abel GA, Friese CR, Magazu LS, et al. Delays in referral and diagnosis for chronic hematologic malignancies: a literature review. Leuk Lymphoma. 2008; 49: 1352-1359. (Pubitemid 352015799)
6. Sekeres MA, Elson P, Kalaycio ME, et al. Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood. 2009; 113: 28-36.
7. Committee on Quality of Health Care in America IoM. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
8. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2006.
9. Altekruse S, Kosary C, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
10. Shanafelt TD, Call TG., Current approach to diagnosis and management of chronic lymphocytic leukemia. Mayo Clin Proc. 2004; 79: 388-398. (Pubitemid 38269240)
11. Swerdlow SH, Harris NL, Jaffe ES, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Geneva: World Health Organization; 2008: 180-182.
12. The NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin′s Lymphoma (Version 4.2009). NCCN.org. Accessed December 11, 2009.
13. Current National Quality Forum-endorsed measures. Accessed March 15, 2010.
14. Friese CR, Abel GA, Magazu LS, Neville BA, Richardson LC, Earle CC., Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma. 2009; 50: 392-400.
15. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002; 40:(8 suppl):IV-3-18.
16. Zippin C, Lum D, Hankey BF., Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer. 1995; 76: 2343-2350.
17. Klabunde CN, Potosky AL, Legler JM, Warren JL., Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53: 1258-1267. (Pubitemid 32007842)
18. Earle CC, Schrag D, Neville BA, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006; 98: 172-180. (Pubitemid 43205479)
19. SEER-Medicare: Defining the Date of Diagnosis & Treatment. Bethesda, MD: National Cancer Institute; 2007. Accessed December 14, 2009.
20. Allison PD., Survival analysis using the SAS system: a practical guide. Cary, NC: SAS Institute, 1995.
21. Rittenhouse DR, Shortell SM., The patient-centered medical home: will it stand the test of health reform? JAMA. 2009; 301: 2038-2040.
22. Williams PA, Williams M., Barriers and incentives for primary care physicians in cancer prevention and detection. Cancer. 1988; 61: 2382-2390.
23. Triezenberg DJ, Smith MA, Holmes TM., Cancer screening and detection in family practice: a MIRNET study. J Fam Pract. 1995; 40: 27-33.
24. Piga A, Graziano F, Zahra G, Cellerino R., Attitudes of non-oncology physicians dealing with cancer patients. A survey based on clinical scenarios in Ancona province, central Italy. Tumori. 1996; 82: 423-429.
25. Stephenson A, From L, Cohen A, Tipping J., Family physicians′ knowledge of malignant melanoma. J Am Acad Dermatol. 1997; 37: 953-957. (Pubitemid 28016625)
26. Canto MT, Horowitz AM, Drury TF, Goodman HS., Maryland family physicians′ knowledge, opinions and practices about oral cancer. Oral Oncol. 2002; 38: 416-424. (Pubitemid 34756726)
27. Dighiero G, Maloum K, Desablens B, et al. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med. 1998; 338: 1506-1514.
28. Meischke H, Larsen MP, Eisenberg MS., Gender differences in reported symptoms for acute myocardial infarction: impact on prehospital delay time interval. Am J Emerg Med. 1998; 16: 363-366. (Pubitemid 28321979)
29. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005; 353: 671-682. (Pubitemid 41175675)
30. Molica S., Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leuk Lymphoma. 2006; 47: 1477-1480. (Pubitemid 44364010)
31. Hartley D, Quam L, Lurie N., Urban and rural differences in health insurance and access to care. J Rural Health. 1994; 10: 98-108. (Pubitemid 24170996)
32. Zent CS, Kyasa MJ, Evans R, Schichman SA., Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer. 2001; 92: 1325-1330.